Well-tolerated chemoprophylaxis uniformly prevented Swedish soldiers from Plasmodium falciparum malaria in Liberia, 2004-2006

Military Medicine

Volumn 173, Issue 12, 2008, Pages 1194-1198

  Andersson, Håkan ^a   Askling, Helena H ^b   Falck, Björn ^a   Rombo, Lars ^b,c  

^a Forsvarsmakten i Halmstad   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Sormland County Council   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; MEFLOQUINE;

ADULT; ANOREXIA; ANXIETY; ARTICLE; CHEMOPROPHYLAXIS; CONCENTRATION LOSS; CONTROLLED STUDY; COUGHING; DEPRESSION; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; HAIR LOSS; HEADACHE; HUMAN; LIBERIA; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MEMORY DISORDER; MILITARY DEPLOYMENT; MOUTH ULCER; MYALGIA; NAUSEA AND VOMITING; NIGHTMARE; NORMAL HUMAN; PLASMODIUM FALCIPARUM; QUESTIONNAIRE; RASH; RETROSPECTIVE STUDY; SELF REPORT; SIDE EFFECT; SLEEP DISORDER; SOLDIER; STOMACH PAIN; SWEDEN; UNSPECIFIED SIDE EFFECT;

EID: 57449106087     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.173.12.1194     Document Type: Article

References (18)

1. Phillips-Howard PA, Radalowicz A, Mitchell J, Bradley DJ: Risk of malaria in British residents from malarious areas. Br Med J 1990; 300: 499-503.
2. Jelinek T, Schulte C, Behrens R, et al: Imported falciparum malaria in Europe: sentinel surveillance data from the European Network on surveillance of imported infectious diseases. Clin Infect Dis 2002; 34: 572-6.
3. Askling HH, Nilsson J, Tegnell A, Janzon R, Ekdahl K: Malaria risk in travelers. Emerg Infect Dis 2005; 11: 436-41.
4. McCarthy AE: Military perspectives for malaria prevention. In: Travelers' Malaria, pp 277-84. Edited by Schlagcnhauf P. Hamilton, Canada, Dekker, Inc., 2001, 277-284.
5. Palmer KJ, Holliday SM, Brogden RN: Mefloquine: a review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1993; 45: 430-75.
6. National Guidelines for Malaria Prophylaxis 2007 [in Swedish]. Swedish Institute for Infectious Diseases Control. Available at http://www. smittskyddsinstitutet.se; accessed September 1, 2007.
7. Björkman A, Hednian P, Brohult J, et al: Different malaria control activities in an area of Liberia: effects on malariometric parameters. Ann Trop Med Parasitol 1985; 79: 239-46.
8. Fox CH: Malaria: Liberia (USA military personnel). ProMEDmail 2003 18 Oct;20031018.2623. Available at http://www.promedmail.org; accessed October 18, 2008.
9. Migliani R, Josse R, Hovette P, et al: Malaria in military personnel: the case of the Ivory Coast: 2002-2003 [text in French with an English abstract]. Med Trop 2003; 63: 282-6.
10. Jansson A, Arneborn M, Ekdahl K: Sensitivity of the Swedish statutory surveillance system for communicable diseases 1998-2002, assessed by the capture-recapture method. Epidemiol Infect 2005; 133: 401-7.
11. Overbosch D, Schilthuis H, Bienzle U, et al: Malarone International Study Team: atovaquone-proguanil versus mefloquine for malaria prophylaxis in non-immune travelers: results from a randomized, double-blind study. Clin Infect Dis 2001; 33: 1015-21.
12. Schlagenhauf P, Tschopp A, Johnson R, et al: Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double-blind, four-arm study. Br Med J 2003; 327: 1078-81.
13. van Riemsdijk MM, Sturkenboom MC, Ditters JM, et al: Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine. Br J Clin Pharmacol 2003; 57: 506-12.
14. Ollivier L, Tifratene K, Josse R, Keundjian A, Boutin JP: The relationship between body weight and tolerance to mefloquine prophylaxis in non-immune adults: results of a questionnaire-based study. Ann Trop Med Parasit 2004; 98: 639-41.
15. Wichmann O, Behrens R, Jelinek T: Malarone for malaria prophylaxis: differences in national recommendations across Europe. Eurosurveillance Weekly [1812-075X], March 11, 2004; 3: 11. Available at http://www.eurosurveillance. org/ew/2004/040311.asp#1; accessed March 11, 2004.
16. Petersen E: The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults. J Travel Med 2003; 10(Suppl 1): S13-5.
17. van Genderen PJJ, Koene HRA, Spong K, Overbosch D: The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of Plasmodium falciparum malaria in non-immune travelers and expatriates. J Travel Med 2007; 14: 92-5.
18. Simons R, Valk PJL, Krul AJ: Malaria prophylaxis for aircrew: safety of atovaquone/proguanil in healthy volunteers under aircraft cabin pressure conditions. J Travel Med 2005; 12: 210-6.